Published in Med Pediatr Oncol on January 01, 1979
Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission. N Engl J Med (1998) 5.98
All-trans-retinoic acid in acute promyelocytic leukemia. N Engl J Med (1997) 4.79
A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer. N Engl J Med (1990) 4.66
Hypersensitivity reactions from taxol. J Clin Oncol (1990) 3.83
Pseudomonas aeruginosa resistant to carbenicillin and gentamicin. Epidemiologic and clinical aspects in a cancer center. Ann Intern Med (1973) 3.81
Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinib. Leukemia (2008) 3.58
Staphylococcus epidermidis: an increasing cause of infection in patients with granulocytopenia. Ann Intern Med (1982) 2.97
Origin of infection in acute nonlymphocytic leukemia. Significance of hospital acquisition of potential pathogens. Ann Intern Med (1972) 2.75
Arabinosyl cytosine: a useful agent in the treatment of acute leukemia in adults. Blood (1968) 2.71
Acute megakaryocytic leukemia: the Eastern Cooperative Oncology Group experience. Blood (2000) 2.65
Treatment of invasive aspergillosis: relation of early diagnosis and treatment to response. Ann Intern Med (1977) 2.52
Fluorouracil and recombinant alfa-2a-interferon: an active regimen against advanced colorectal carcinoma. J Clin Oncol (1989) 2.36
Leukemogenic potential of adjuvant chemotherapy for early-stage breast cancer: the Eastern Cooperative Oncology Group experience. J Clin Oncol (1995) 2.33
A Coagulation Defect Produced by Nitrogen Mustard. Science (1948) 2.26
Hemangioendothelial sarcoma of liver from chronic arsenic intoxication by Fowler's solution. Cancer (1968) 2.22
Torsades de pointes in 3 patients with leukemia treated with arsenic trioxide. Blood (2001) 2.20
Filtration leukapheresis for granulocyte transfusion therapy. Clinical and laboratory studies. N Engl J Med (1975) 2.16
Adriamycin chemotherapy--efficacy, safety, and pharmacologic basis of an intermittent single high-dosage schedule. Cancer (1974) 2.10
Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung. N Engl J Med (1987) 2.05
Systemic lupus erythematosus and B-cell hematologic neoplasm. Lupus (2001) 2.04
Amputation and adriamycin in primary osteosarcoma. N Engl J Med (1974) 2.04
Written informed consent in patients with breast cancer. Cancer (1979) 2.01
Prognostic factors in metastatic breast cancer. Cancer Clin Trials (1981) 1.96
Two cases of severe clinical and histologic hepatotoxicity associated with troglitazone. Ann Intern Med (1998) 1.95
An intensive sequenced adjuvant chemotherapy regimen for breast cancer. Cancer Invest (1993) 1.94
Oncologists' reply: survival expectancy in acute lymphocytic leukemia. N Engl J Med (1972) 1.89
Interrupted versus continuous chemotherapy in patients with metastatic breast cancer. The Piedmont Oncology Association. N Engl J Med (1991) 1.89
Complete deficiency of leukocyte glucose-6-phosphate dehydrogenase with defective bactericidal activity. J Clin Invest (1972) 1.85
Association of Epstein-Barr virus with thymic carcinoma. N Engl J Med (1985) 1.83
Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia: a CALGB study. Blood (1982) 1.79
Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo. J Urol (2000) 1.78
Neurotoxicity of commonly used antineoplastic agents (second of two parts). N Engl J Med (1974) 1.77
Diffuse malignant mesothelioma. Prospective evaluation of 69 patients. Ann Intern Med (1982) 1.75
Detection of mammary tumor virus env gene-like sequences in human breast cancer. Cancer Res (1995) 1.75
Phase I clinical and pharmacokinetic study of taxol. Cancer Res (1987) 1.74
Elevated serum ribonuclease in patients with pancreatic cancer. Proc Natl Acad Sci U S A (1976) 1.74
Adjuvant chemotherapy of breast cancer. Cancer (1979) 1.73
Quantification of arabinitol in serum by selected ion monitoring as a diagnostic technique in invasive candidiasis. J Clin Microbiol (1980) 1.70
Psychological symptoms and disease-free and overall survival in women with stage II breast cancer. Cancer and Leukemia Group B. J Natl Cancer Inst (1996) 1.70
Treatment of acute myelocytic leukemia: a study by cancer and leukemia group B. Blood (1981) 1.68
Phase I trial of a human-mouse chimeric anti-disialoganglioside monoclonal antibody ch14.18 in patients with refractory neuroblastoma and osteosarcoma. J Clin Oncol (1998) 1.67
Malignant seeding of the tract after thin-needle aspiration biopsy. Radiology (1979) 1.63
Pulmonary complications of bone marrow transplantation. Chest (1985) 1.63
An opportunistic infection with Corynebacterium pyogenes producing empyema. Am J Clin Pathol (1970) 1.62
Sudden death in cancer patient on high-dose domperidone. Lancet (1982) 1.60
Disseminated strongyloidiasis with central nervous system involvement diagnosed antemortem in a patient with acquired immunodeficiency syndrome and Burkitts lymphoma. Cancer (1990) 1.59
A randomized trial of anticoagulation with warfarin and of alternating chemotherapy in extensive small-cell lung cancer by the Cancer and Leukemia Group B. J Clin Oncol (1989) 1.56
Reovirus infection of cancer cells is not due to activated Ras pathway. Cancer Gene Ther (2008) 1.56
Infection prevention in acute nonlymphocytic leukemia. Laminar air flow room reverse isolation with oral, nonabsorbable antibiotic prophylaxis. Ann Intern Med (1975) 1.53
Piperacillin or ticarcillin plus amikacin. A double-blind prospective comparison of empiric antibiotic therapy for febrile granulocytopenic cancer patients. Am J Med (1981) 1.53
VP-16-213 monotherapy for remission induction of small cell lung cancer: a randomized trial using three dosage schedules. Cancer Treat Rep (1978) 1.51
Significance of Pseudomonas aeruginosa in the patient with leukemia or lymphoma. J Infect Dis (1974) 1.51
Chemotherapy of acute lymphocytic leukemia of childhood. Cancer (1972) 1.50
Prolonged venous access for chemotherapy by means of the Hickman catheter. Cancer (1983) 1.49
Chronic Epstein-Barr virus infection associated with fever and interstitial pneumonitis. Clinical and serologic features and response to antiviral chemotherapy. Ann Intern Med (1986) 1.48
Utility of embolization or chemoembolization as second-line treatment in patients with advanced or recurrent colorectal carcinoma. Cancer (1994) 1.46
Management of hypocalcemic effects of WR2721 administered on a daily times five schedule with cisplatin and radiation therapy. The New York Gynecologic Oncology Group. J Clin Oncol (1993) 1.46
Diffuse pulmonary malignant mesothelioma: response to doxorubicin and 5-azacytidine. Cancer (1978) 1.45
ANDROGENS AND TUMOR GROWTH. Science (1939) 1.45
Mouse mammary tumor virus-like ENV gene sequences in human breast tumors and in a lymphoma of a breast cancer patient. Clin Cancer Res (2000) 1.45
Radiation therapy versus combination chemotherapy in the treatment of early-stage Hodgkin's disease: seven-year results of a prospective randomized trial. J Clin Oncol (1991) 1.44
Hodgkin disease survivors at increased risk for problems in psychosocial adaptation. The Cancer and Leukemia Group B. Cancer (1992) 1.44
Factors affecting survival in nocardiosis. Am Rev Respir Dis (1973) 1.44
Phase I trial of taxol given as a 24-hour infusion every 21 days: responses observed in metastatic melanoma. J Clin Oncol (1987) 1.44
Fluorometric investigations of the interaction of polyene antibiotics with sterols. Biochemistry (1972) 1.42
Upregulation of vascular endothelial growth factor by cobalt chloride-simulated hypoxia is mediated by persistent induction of cyclooxygenase-2 in a metastatic human prostate cancer cell line. Clin Exp Metastasis (1999) 1.42
Diaminodichloroplatinum: a phase I study showing responses in testicular and other tumors. Cancer (1974) 1.42
Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome. Blood (2000) 1.41
Anticipation in familial plasma cell dyscrasias. Br J Haematol (1998) 1.41
Improved prognosis for granulocytopenic patients with gram-negative bacteremia. Am J Med (1980) 1.40
Rectal abscesses in cancer patients. Lancet (1972) 1.40
Pulmonary microvascular fat: the significance? Crit Care Med (1993) 1.39
Acute promyelocytic leukemia: another pseudoleukemia? Blood (1990) 1.38
Four-drug combination chemotherapy (methotrexate, cyclophosphamide, hexamethylmelamine, and CCNU) for non-small cell bronchogenic carcinoma: a Cancer and Leukemia Group B study. J Clin Oncol (1983) 1.38
Identification of a proviral structure in human breast cancer. Cancer Res (2001) 1.37
Long-term survival in acute myeloid leukemia: the Eastern Cooperative Oncology Group experience. Cancer (1997) 1.36
Biochemical and pharmacological studies with asparaginase in man. Cancer Res (1970) 1.34
Clinical presentation of infection in granulocytopenic patients. Arch Intern Med (1975) 1.33
Improved therapy with cisplatin regimens for patients with ovarian carcinoma (FIGO Stages III and IV) as measured by surgical end-staging (second-look operation). Am J Obstet Gynecol (1983) 1.33
Clinical significance of serum and urinary muramidase activity in leukemia and other hematologic malignancies. Am J Med (1969) 1.33
Granulocytic sarcoma (chloroma). Blood (1970) 1.33
Phase II study and long-term follow-up of patients treated with taxol for advanced ovarian adenocarcinoma. J Clin Oncol (1992) 1.33
Factors effecting remission and survival in adult acute nonlymphocytic leukemia (ANLL). Medicine (Baltimore) (1970) 1.32
Effect of two cancer chemotherapeutic agents on the antibacterial activity of three antimicrobial agents. Antimicrob Agents Chemother (1978) 1.31
Randomized trial of empiric antibiotic therapy with ticarcillin in combination with gentamicin, amikacin or netilmicin in febrile patients with granulocytopenia and cancer. Am J Med (1979) 1.31
Cytosine arabinoside (NSC-63878) and daunorubicin (NSC-83142) therapy in acute nonlymphocytic leukemia. Cancer Chemother Rep (1974) 1.30
Role of murine tumor models in cancer treatment research. Cancer Res (1986) 1.30
Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathological stage II testicular cancer. N Engl J Med (1987) 1.30
Lymphocyte function of Michigan dairy farmers exposed to polybrominated biphenyls. Science (1978) 1.30
Preoperative chemotherapy, surgical resection, and selective postoperative therapy for squamous cell carcinoma of the esophagus. Ann Thorac Surg (1988) 1.30